Bml Capital Management, LLC Achilles Therapeutics PLC Transaction History
Bml Capital Management, LLC
- $161 Billion
- Q4 2024
A detailed history of Bml Capital Management, LLC transactions in Achilles Therapeutics PLC stock. As of the latest transaction made, Bml Capital Management, LLC holds 4,100,002 shares of ACHL stock, worth $5.66 Million. This represents 2.9% of its overall portfolio holdings.
Number of Shares
4,100,002
Previous 4,100,002
-0.0%
Holding current value
$5.66 Million
Previous $4.18 Billion
11.76%
% of portfolio
2.9%
Previous 2.46%
Shares
2 transactions
Others Institutions Holding ACHL
# of Institutions
23Shares Held
24.3MCall Options Held
0Put Options Held
0-
Syncona Portfolio LTD Guernsey, Channel Islands, X011.1MShares$15.3 Million23.86% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.39MShares$3.3 Million0.42% of portfolio
-
Redmile Group, LLC San Francisco, CA1.61MShares$2.22 Million0.11% of portfolio
-
Vestal Point Capital, LP New York, NY1.5MShares$2.07 Million0.12% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.44MShares$1.99 Million0.26% of portfolio
About Achilles Therapeutics plc
- Ticker ACHL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,774,000
- Market Cap $56.3M
- Description
- Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...